India develops innovative treatment for Alzheimer’s disease

Researchers at the Institute of Nano Science and Technology have developed a new Alzheimer’s disease therapy based on multifunctional nanoparticles. The development was reported by
IANS, a partner of TV BRICS.

Conventional Alzheimer’s therapies usually target only a single pathological feature, which limits their clinical effectiveness.

The new treatment is based on nanoparticles containing green tea polyphenols, a neurotransmitter and an amino acid. These nanoparticles are designed to counter amyloid aggregation, reduce oxidative stress, alleviate inflammation and prevent neuronal degeneration.

The nanoparticles are synthesised using biocompatible methods such as hydrothermal treatment and electrostatic incubation.

The study presents a comprehensive approach that addresses multiple aspects of Alzheimer’s disease, thereby opening up new prospects for its treatment. The nanoparticles are able not only to eliminate plaques but also to lower stress levels in the brain, reduce inflammation and stimulate the growth of nerve cells.

BRICS countries are also actively engaged in research into innovative therapies. According to
Toda Palavra, a partner of TV BRICS, Brazilian researchers are working intensively on the development of new methods to treat Alzheimer’s disease. They have found that blood tests can be used effectively to diagnose the condition. The tau217 protein is used as a key biomarker, enabling the disease to be successfully detected.

For example, in Russia, scientists at Peter the Great St. Petersburg Polytechnic University have
developed nanoparticles for the treatment of melanoma. These nanoparticles protect drugs from gastrointestinal degradation, ensuring maximum effectiveness of oral targeted cancer therapy.

China has proposed a method for detecting osteoporosis in humans. This was reported by
Alalam News Agency, a partner of TV BRICS. Researchers suggest using levels of alkaline phosphatase in the blood to identify the risk of the disease. Mildly elevated levels of alkaline phosphatase are more common among people with low bone density.

Photo: gorodenkoff /
iStock

Самые
актуальные новости стран БРИКС https://tvbrics.com  

 

Share your love